We want to ensure optimum use of our website for you, and to continually improve our website. Therefore, we work with selected partners (e.g. Pardot). You can revoke your voluntary consent at any time. You can find further information and setting options under „Configure“ and in our data protection information.
ELEKTA APPOINTS NEW HEAD OF NORTH AMERICAN OPERATIONS
Elekta has recruited Anthony G. De Carolis as Regional Vice President North America and President & CEO of Elekta Inc., From May 1, Mr. De Carolis will assume responsibility for all Elekta's operations in North America, heading an organization of over 200 employees and managing all sales in North America, which constitutes over 40 percent of Elekta's total sales. In the American market Elekta's treatment methods with radiosurgery are well established with good penetration of the Leksell Gamma Knife®. In the radiation therapy market Elekta is noting continuous success with increased market shares for several years.
- I am truly excited about joining Elekta, a company that has established itself as a technology leader in the radiosurgery and radiation therapy markets, says Anthony De Carolis. I see great opportunities in the near future, not least in the ongoing launch on Elekta Synergy®, the world's first radiation therapy treatment platform with integrated equipment for high resolution 3D images. Both in a clinical sense and business wise I expect Elekta and its US based staff to continue its success in the American market, De Carolis concludes.
Mr. De Carolis has extensive experience from sales of medical technology capital equipment. With over 20 successful years in senior positions at General Electric Medical Systems, Toshiba America Medical Systems and Fisher Imaging Corporation, Anthony De Carolis will be a strong addition to Elekta's expanding operations in North America.
Tomas Puusepp, Executive Vice President - Sales, Marketing & Service at Elekta, who previously has been the acting head of Elekta's operations in North America, will now be able to fully focus on the Company's global development.